Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Female Sex Hormones, Menstrual Cycle, Oral Contraceptives, Protein Metabolism

In brief

The muscles of the body are constantly breaking down old proteins and building new ones. These two processes, protein breakdown and protein synthesis, together are known as protein turnover. Protein turnover is essential for maintaining healthy muscle. Despite its importance, females have historically been underrepresented in protein metabolism research. A long-standing assumption has been that fluctuations in female sex hormones such as estrogen and progesterone, whether across the natural menstrual cycle or in individuals using oral contraceptives (OCs), make metabolism and training responses too variable to study. Because of this, many researchers have excluded female participants for logistical reasons. Resistance exercise, such as weightlifting, is the most effective way to increase muscle size and strength. Each resistance-training session triggers muscle protein synthesis (MPS), the process by which new muscle proteins are built. Consuming dietary protein or individual amino acids further increases the rate at which new proteins are formed. Over time, higher rates of protein synthesis support muscle growth and the maintenance of other lean tissues in the body. The purpose of this study is to examine how menstrual cycle phases and OC use influence the synthesis of proteins in both muscle tissue and the rest of the body. Improving scientific understanding in this area will support more effective, evidence-based training and nutrition recommendations for females.

Key facts

Study ID: NCT07258576
Run by: University of Toronto
People needed: 20
Starts: 2025-07-20
Expected to finish: 2026-09-01
Last updated by the study team: 2025-12-02

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

Age: 18-40 years
BMI between 18.5-29.9 kg/m2 (non-obese)
Recreationally active (resistance train minimum twice a week)
Using monophasic or triphasic oral contraceptives for >1 year (for oral contraceptive users)
Have regular menstrual cycles (21-35 days) for the past 3 months and discontinued any hormonal contraceptive use for at least 6 months (non-oral contraceptive users)
Must meet a progesterone sufficiency test (non-oral contraceptive users)

You may not qualify if…

Mid-luteal progesterone levels <16umol
Chronic disease diagnosis (cardiovascular, thyroid, diabetes)
Current or recent remission of cancer
Regular use of non-steroidal anti-inflammatory drugs (NSAIDs; except low-dose aspirin), anticoagulants
Use of prescription drugs that would impact muscle protein synthesis, e.g. Statins, Lithium, ADHD medication.
Insertion of intrauterine device (IUD) - exception: copper
Use of emergency contraception in the last 3 months (e.g. Plan B)
Severe food allergies (e.g. soy, nuts)
Smoking, use of performance enhancing drugs (growth hormones, testosterone)

Where it is running

Goldring Center for High Performance Sport — Toronto, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.